Quave Lab awarded grant for cancer research

Dr. Quave (Principal investigator) in collaboration with Co-investigators Dr. Jack Arbiser (Emory Dermatology) and Dr. Yuhong Du (Emory Chemical Biology Discovery Center) have received a $50,000 grant from the Winship Invest$ award, made possible through the Melanoma Innovation Fund, a philanthropic fund established at Emory’s Winship Cancer Institute by anonymous…

Continue reading

Support Research & Student Training

Would you like to support research (http://bit.ly/1MZvBcQ) directed at the discovery and development of new antibiotics to treat life-threatening superbug infections? Your tax-deductible donation to the Quave Lab could make a real difference in advancing our research efforts! Funds are needed to support student research projects and the purchase of…

Continue reading

Our work on Chestnut and MRSA featured in BioTechniques

Excerpt from the piece: Cutting Off Communication Researchers have found a plant extract that halts Staphylococcus aureus infections without promoting resistance. Will this lead to a new way to treat bacterial infections? Read more… http://www.biotechniques.com/news/Cutting-Off-Communication/biotechniques-360385.html#.VfGkmfm2Vsv

Continue reading

New publication on MRSA in PLOS ONE

A new publication is out on a collaborative project between the Quave Lab (Emory University) and Horswill Lab (University of Iowa). Their latest study reports on the anti-virulence activity of compounds from Chestnut leaves. The extract blocks virulence by switching off the pathways necessary for the production of toxins. The…

Continue reading

8/17: Quave to speak at Georgia Herbalists Guild

Topic: Medical ethnobotany and the discovery of new drugs for antibiotic resistant infections Dr. Quave will tell the story of how her research group has discovered new leads for antibiotic adjuvants, from field research documenting the traditional use of these plants in topical therapeutics for skin infections, to the laboratory…

Continue reading